- ¥175bn
- ¥363bn
- ¥274bn
Table: Towa Pharmaceutical -2021/22 group forecast
2021 6-month group forecast
Table: Towa Pharmaceutical -Q1 group results
Brief: Breckenridge Pharmaceutical Inks Multi-Product Agreement With Aggrega Pharma
Brief: Breckenridge Announces Approval of its ANDA for Carfilzomib Intravenous Powder, generic for Kyprolis
Table: Towa Pharmaceutical -2020/21 parent results
Table: Towa Pharmaceutical -2020/21 group results
Table: Towa Pharmaceutical - 9-MTH group results
Table: Towa Pharmaceutical -2020/21 group forecast
Table: Towa Pharmaceutical - 6-MTH group results
Table: Towa Pharmaceutical -Q1 group results
Table: Towa Pharmaceutical -2019/20 parent results
Table: Towa Pharmaceutical -2019/20 group results
Table: Towa Pharmaceutical -2019/20 group forecast
Table: Towa Pharmaceutical - 9-MTH group results
Table: Towa Pharmaceutical - 6-MTH group results
Table: Towa Pharmaceutical -Q1 group results
Table: Towa Pharmaceutical -2018/19 group results
Table: Towa Pharmaceutical -2018/19 parent results